{"AllianceGenome": "3118", "HGNC": "3118", "MIM": "600659", "_id": "1874", "_version": 1, "accession": {"genomic": ["AC040160.4", "AF250378.1", "AF527540.1", "CH471092.1", "CP068262.2", "HI179032.1", "KT583874.1", "NC_000016.10", "NC_060940.1"], "protein": ["AAB32597.1", "AAC50119.1", "AAF65226.1", "AAH33180.1", "AAM77918.1", "BAG70106.1", "BAG70239.1", "CAA60050.2", "CBX53825.1", "EAW83094.1", "EAW83095.1", "EAW83096.1", "NP_001941.2", "Q16254.2"], "rna": ["AB451292.1", "AB451425.1", "BC021050.1", "BC031071.1", "BC033180.1", "BU857680.1", "NM_001950.4", "S75174.1", "U15641.1", "X86096.1"], "translation": [{"protein": "NP_001941.2", "rna": "NM_001950.4"}, {"protein": "AAB32597.1", "rna": "S75174.1"}, {"protein": "BAG70106.1", "rna": "AB451292.1"}, {"protein": "AAC50119.1", "rna": "U15641.1"}, {"protein": "BAG70239.1", "rna": "AB451425.1"}, {"protein": "AAH33180.1", "rna": "BC033180.1"}, {"protein": "CAA60050.2", "rna": "X86096.1"}]}, "alias": "E2F-4", "ensembl": {"gene": "ENSG00000205250", "protein": ["ENSP00000368686", "ENSP00000454477", "ENSP00000457239", "ENSP00000458082", "ENSP00000458706"], "transcript": ["ENST00000379378", "ENST00000561904", "ENST00000563238", "ENST00000564718", "ENST00000565226", "ENST00000565849", "ENST00000566368", "ENST00000567007", "ENST00000567228", "ENST00000568485", "ENST00000568693", "ENST00000568839", "ENST00000569573"], "translation": [{"protein": "ENSP00000368686", "rna": "ENST00000379378"}, {"protein": "ENSP00000454477", "rna": "ENST00000565849"}, {"protein": "ENSP00000458082", "rna": "ENST00000568839"}, {"protein": "ENSP00000457239", "rna": "ENST00000569573"}, {"protein": "ENSP00000458706", "rna": "ENST00000565226"}], "type_of_gene": "protein_coding"}, "entrezgene": "1874", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 12.5108646037, "exp_mis": 127.573900892, "exp_syn": 60.1790691267, "lof_z": 2.66358168250499, "mis_z": 1.10747131999397, "mu_lof": 9.12397179733e-07, "mu_mis": 1.32527057904e-05, "mu_syn": 6.15133317448e-06, "n_lof": 3.0, "n_mis": 102.0, "n_syn": 66.0, "p_li": 0.320999401239657, "p_null": 0.00349353376700854, "p_rec": 0.675507064993334, "syn_z": -0.465177913220247}, "bp": 1242, "cds_end": 67232026, "cds_start": 67226130, "n_exons": 10, "nonpsych": {"exp_lof": 11.143633948, "exp_mis": 115.286788443, "exp_syn": 54.2879557808, "lof_z": 2.69003156405531, "mis_z": 1.42273911811391, "mu_lof": 9.12397179733e-07, "mu_mis": 1.32527057904e-05, "mu_syn": 6.15133317448e-06, "n_lof": 2.0, "n_mis": 85.0, "n_syn": 65.0, "p_li": 0.628180045867701, "p_null": 0.00185268539015984, "p_rec": 0.369967268742139, "syn_z": -0.915343154351286}, "nontcga": {"exp_lof": 11.4924596539, "exp_mis": 117.350460993, "exp_syn": 55.3472064418, "lof_z": 2.47120203959443, "mis_z": 1.21186892270944, "mu_lof": 9.12397179733e-07, "mu_mis": 1.32527057904e-05, "mu_syn": 6.15133317448e-06, "n_lof": 3.0, "n_mis": 91.0, "n_syn": 60.0, "p_li": 0.251142728807308, "p_null": 0.00624623302154913, "p_rec": 0.742611038171143, "syn_z": -0.395993319243441}, "transcript": "ENST00000379378.3"}, "exons": [{"cdsend": 67198123, "cdsstart": 67192227, "chr": "16", "position": [[67192154, 67192362], [67192760, 67192870], [67193008, 67193170], [67193471, 67193515], [67194397, 67194459], [67194685, 67194980], [67195781, 67196006], [67197598, 67197646], [67197866, 67197911], [67198007, 67198918]], "strand": 1, "transcript": "NM_001950", "txend": 67198918, "txstart": 67192154}], "exons_hg19": [{"cdsend": 67232026, "cdsstart": 67226130, "chr": "16", "position": [[67226057, 67226265], [67226663, 67226773], [67226911, 67227073], [67227374, 67227418], [67228300, 67228362], [67228588, 67228883], [67229684, 67229909], [67231501, 67231549], [67231769, 67231814], [67231910, 67232821]], "strand": 1, "transcript": "NM_001950", "txend": 67232821, "txstart": 67226057}], "generif": [{"pubmed": 11759817, "text": "expression reduced in primary and metastatic breast carcinoma"}, {"pubmed": 12006580, "text": "regulation of expression of p130, p107 and E2F-4 in human cells"}, {"pubmed": 12055184, "text": "data point to Tat as an adaptor protein that recruits cellular factors such as E2F-4 to exert its multiple biological activities"}, {"pubmed": 12148576, "text": "Mutations in E2F-4 gene is associated with hereditary non-polyposis colorectal cancer"}, {"pubmed": 12789259, "text": "We investigated occupancy of ER-alpha promoter by pRb2/p130-E2F4/5-HDAC1-SUV39 H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 complexes, and provided a link between pRb2/p130 and chromatin-modifying enzymes in the regulation of ER-alpha transcription"}, {"pubmed": 12860972, "text": "EBV LMP1 blocks p16INK4 pathway by promoting nuclear export of E2F-4."}, {"pubmed": 15231644, "text": "Increased E2F4/p130 complex formation seen after irradiation depended on increased nuclear E2F4, dissociation of p130 from Cdk2, and p130 dephosphorylation. E2F4 siRNA prevented p130/E2F4 formation and sensitized cells to radiation-induced apoptosis."}, {"pubmed": 15964557, "text": "E2F-a and E2F-c binding sites are involved in the TCR-induced down-regulation of ICBP90 gene transcription"}, {"pubmed": 16135806, "text": "E2F4 is a transcriptional regulator of the cell cycle genes."}, {"pubmed": 16758952, "text": "There were no significant changes of CDK4 and E2F-1/4 expression in benzo(a)pyrene treated embryo lung fibroblasts."}, {"pubmed": 17001309, "text": "Hypoxia induces substantial p130 dephosphorylation and nuclear accumulation, leading to the formation of E2F4/p130 complexes and increased occupancy of E2F4 and p130 at the RAD51 and BRCA1 promoters."}, {"pubmed": 17043659, "text": "in response to radiation, E2F4 becomes active in the nucleus, enforces a stable G(2) arrest by target gene repression, and thus provides increased cell survival ability by minimizing propagation of cells that have irreparable DNA damage"}, {"pubmed": 17121828, "text": "Wnt/beta-catenin signaling may contribute to colorectal carcinogenesis by reducing the level of the E2F4 cell cycle repressor via an antisense mechanism"}, {"pubmed": 17507799, "text": "By interacting with p130, E2F4 plays a key role in the maintenance of a stable G2 arrest. Increased E2F4 levels and its translocation to the nucleus following genotoxic stress result in downregulation of mitotic genes."}, {"pubmed": 17531812, "text": "Evolutionarily conserved multisubunit protein complex that contains p130 and E2F4 mediates the repression of cell cycle-dependent genes in quiescence."}, {"pubmed": 17656449, "text": "deregulated nuclear E2F4 expression induces apoptosis via multiple pathways in normal intestinal epithelial cells but not in colon cancer cells."}, {"pubmed": 17908821, "text": "E2F4, binding sites are located within 2 kb of a transcription start site, in both normal and tumor cells"}, {"pubmed": 17957245, "text": "Cell cycle genes are the evolutionarily conserved targets of the E2F4 transcription factor"}, {"pubmed": 18368381, "text": "FBI-1 is the first transcriptional repressor shown to act as a dual regulator in adipogenesis exerting repressor activities on target genes by both, direct and indirect mechanisms."}, {"pubmed": 18660489, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19473719, "text": "E2F4, PHACTR3, PRAME family member and CDH12 most probably play important role in non-small-cell lung cancer geneses"}, {"pubmed": 19562678, "text": "E2F4 may be determinant in the promotion of proliferation of human intestinal epithelial crypt cells and colorectal cancer cells."}, {"pubmed": 19738611, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19955219, "text": "Our data indicate that E2F4 is required for cardiomyocyte proliferation and suggest a function for E2F4 in mitosis"}, {"pubmed": 21048031, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 21789246, "text": "Tamoxifen resistant tumors displayed enriched expression of genes related to cell cycle and proliferation, as well as elevated activity of E2F transcription factors."}, {"pubmed": 22357515, "text": "Silica could induce the high expression of cyclin D1 and CDK4 and the low expression of E2F-4, resulting in the cell cycle changes by AP-1/cyclin D1 pathway in human embryonic lung fibroblasts."}, {"pubmed": 22475873, "text": "data demonstrate that enforced E2F4 expression in Burkitt lymphoma (BL) cells not only diminishes E2F1 levels, but also reduces selectively the tumorigenic properties and proliferation of BL cells"}, {"pubmed": 22688350, "text": "The inverse immunohistochemical relationship between E2F1 and E2F4 indicates a possible mechanistic interlink in colorectal cancer."}, {"pubmed": 23007606, "text": "the loss of CDH1/E2F4 may be associated with worse clinical and pathological findings in mammary ductal carcinoma."}, {"pubmed": 23015403, "text": "Short alleles (<13 repeats) of (AGC)n in E2F4 were less frequent in women with breast cancer than in the control sample."}, {"pubmed": 23060449, "text": "Trim28 regulates cell proliferation by bridging HDAC1 and E2F3 and E2F4 interactions."}, {"pubmed": 23093672, "text": "In terminally differentiated cells, common KDM5A and E2F4 gene targets were bound by the pRB-related protein p130, a DREAM complex component."}, {"pubmed": 24096481, "text": "E2F4 promoter occupancy is globally associated with p53-repression targets, but not with p53 activation targets."}, {"pubmed": 24100580, "text": "cancer-associated E2F4 mutations enhance the capacity of colorectal cancer cells to grow without anchorage, thereby contributing to tumor progression."}, {"pubmed": 24109597, "text": "Analysis data from a panel of cell cycle transcription factors (E2F1, E2F4, E2F6, and GABPA) finds that a set of core cell cycle genes regulated in both U2OS and HeLa cells are bound by multiple cell cycle transcription factors."}, {"pubmed": 25650659, "text": "Authors show that BRCA1 and RAD17 genes, whose derived proteins play a pivotal role in DNA damage repair, are transcriptional targets of gain-of-function mutant p53 proteins."}, {"pubmed": 25712098, "text": "Data suggest that aberrant cell cycle activation in Ewing sarcoma is due to the de-repression of transcription factor E2F targets of transcriptional induction and physical recruitment of E2F3 by fusion protein EWS-FLI1 replacing E2F4 on their promoters."}, {"pubmed": 26343152, "text": "This study found evidence that the number of triplet AGC repeats in the E2F4 gene may play a role in the susceptibility to early-onset colorectal cancer."}, {"pubmed": 26369285, "text": "cell cycle-dependent transcription of the TRAIP gene by E2F1, E2F2, and E2F4 and rapid protein degradation leads to cell cycle-dependent expression with a maximum in G2/M"}, {"pubmed": 26751588, "text": "PHF8 reduces the H3K9me2 level at the E2F4 transcriptional start site, demonstrating a direct function of PHF8 in endothelial E2F4 gene regulation"}, {"pubmed": 26856934, "text": "Integrative genomic analyses confirm that E2F4 or E2F1 expression level is high in liposarcoma patients which associate with unfavorable prognosis."}, {"pubmed": 27567532, "text": "The authors found that phosphorylation of residues S650 and S975 in p107 weakens the E2F4 transactivation domain binding."}, {"pubmed": 27983535, "text": "E2F4 gene expression in glioblastoma."}, {"pubmed": 28464832, "text": "Studied expression of E2F4 in breast cancer patients undergoing neoadjuvant chemotherapy; found target gene-based signature of E2F4 can be used to predict neoadjuvant response."}, {"pubmed": 28675157, "text": "E2f4 forms apical cytoplasmic organizing centres for assembly and nucleation of deuterosomes. Using genetically altered mice and E2F4 mutant proteins we demonstrate that centriole amplification is crucially dependent on these organizing centres and that, without cytoplasmic E2f4, deuterosomes are not assembled, halting multiciliogenesis"}, {"pubmed": 29059406, "text": "A point mutation in LxCxE motif of KDM5A/RBP2 renders it incapable of 130 kDa retinoblastoma-associated protein (p130)-interaction and hence, repression of E2F transcription factor 4 and (E2F)-regulated gene promoters."}, {"pubmed": 29987913, "text": "overexpressing p130 or E2F4 significantly improved migration but not proliferation of mMSCs. Our data suggest that cell cycle regulation may be involved in p130/E2F4-mediated changes in the multipotential abilities of bone-marrow-derived mesenchymal stem cells (MSCs)."}, {"pubmed": 30053437, "text": "E2F4 transcriptional repressor physically associates to the VHL demethylated promoter. These observations together with the finding of elevated E2F4 levels in early-onset preeclampsia (E-PE) placentae suggest that E2F4 inactivates VHL gene expression in E-PE due to enhanced binding to the VHL promoter as a consequence of the reduced methylation status of its binding site."}, {"pubmed": 30166342, "text": "HSP27 promotes cell cycle progression of MRC-5 cells by suppressing expression of the transcriptional repressors E2F-4 and p130"}, {"pubmed": 31943751, "text": "E2F4 functions as a tumour suppressor in acute myeloid leukaemia via inhibition of the MAPK signalling pathway by binding to EZH2."}, {"pubmed": 32239565, "text": "Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4."}, {"pubmed": 32314545, "text": "LncRNA HAND2-AS1 represses cervical cancer progression by interaction with transcription factor E2F4 at the promoter of C16orf74."}, {"pubmed": 33609534, "text": "Involvement of TFAP2A in the activation of GSDMD gene promoter in hyperoxia-induced ALI."}, {"pubmed": 33767277, "text": "Genome-wide transcriptome study in skin biopsies reveals an association of E2F4 with cadasil and cognitive impairment."}, {"pubmed": 34260288, "text": "E2F4's cytoplasmic role in multiciliogenesis is mediated via an N-terminal domain that binds two components of the centriole replication machinery, Deup1 and SAS6."}, {"pubmed": 35262965, "text": "E2F4 may be a core transcription factor in the lncRNA-TF regulatory network in cervical cancer."}, {"pubmed": 35840663, "text": "E2F4 transcription factor is a prognostic biomarker related to immune infiltration of head and neck squamous cell carcinoma."}, {"pubmed": 36567912, "text": "High Expression of E2F4 Is an Adverse Prognostic Factor and Related to Immune Infiltration in Oral Squamous Cell Carcinoma."}, {"pubmed": 37349788, "text": "Enhancer-driven transcription of MCM8 by E2F4 promotes ATR pathway activation and glioma stem cell characteristics."}, {"pubmed": 37567906, "text": "Transcriptional induction of NF-kappaB-inducing kinase by E2F4/5 facilitates collective invasion of GBM cells."}], "genomic_pos": {"chr": "16", "end": 67198918, "ensemblgene": "ENSG00000205250", "start": 67192155, "strand": 1}, "genomic_pos_hg19": {"chr": "16", "end": 67232821, "start": 67226072, "strand": 1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0002064", "qualifier": "involved_in", "term": "epithelial cell development"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006357", "qualifier": "involved_in", "term": "regulation of transcription by RNA polymerase II"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006884", "qualifier": "involved_in", "term": "cell volume homeostasis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0008015", "qualifier": "involved_in", "term": "blood circulation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0009887", "qualifier": "involved_in", "term": "animal organ morphogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0042127", "qualifier": "involved_in", "term": "regulation of cell population proliferation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0044458", "qualifier": "involved_in", "term": "motile cilium assembly"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045944", "pubmed": 11418595, "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045944", "qualifier": "involved_in", "term": "positive regulation of transcription by RNA polymerase II"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0098534", "qualifier": "involved_in", "term": "centriole assembly"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1903251", "qualifier": "involved_in", "term": "multi-ciliated epithelial cell differentiation"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0000785", "pubmed": 21454377, "qualifier": "part_of", "term": "chromatin"}, {"evidence": "ISA", "gocategory": "CC", "id": "GO:0000785", "qualifier": "part_of", "term": "chromatin"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005737", "pubmed": 17062573, "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0090575", "qualifier": "part_of", "term": "RNA polymerase II transcription regulator complex"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0000978", "qualifier": "enables", "term": "RNA polymerase II cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0000978", "pubmed": 10488129, "qualifier": "enables", "term": "RNA polymerase II cis-regulatory region sequence-specific DNA binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "ISA", "id": "GO:0000981", "qualifier": "enables", "term": "DNA-binding transcription factor activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IDA", "id": "GO:0001216", "pubmed": 17062573, "qualifier": "enables", "term": "DNA-binding transcription activator activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0001228", "pubmed": 11418595, "qualifier": "enables", "term": "DNA-binding transcription activator activity, RNA polymerase II-specific"}, {"category": "MF", "evidence": "IMP", "id": "GO:0003677", "pubmed": 11418595, "qualifier": "enables", "term": "DNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003700", "pubmed": 11418595, "qualifier": "enables", "term": "DNA-binding transcription factor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [11418595, 14532282, 16061792, 16360038, 17062573, 17159899, 17531812, 20133863, 22002537, 22810586, 24981860, 27705803, 32296183, 34591612, 34591642], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0019904", "pubmed": 16360038, "qualifier": "enables", "term": "protein domain specific binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0046983", "qualifier": "enables", "term": "protein dimerization activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:1990837", "pubmed": 28473536, "qualifier": "enables", "term": "sequence-specific double-stranded DNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:1990841", "pubmed": 25100735, "qualifier": "enables", "term": "promoter-specific chromatin binding"}]}, "homologene": {"genes": [[7955, 406741], [8364, 100038079], [9031, 769430], [9544, 696864], [9598, 454158], [9606, 1874], [9615, 611243], [9913, 525428], [10090, 104394], [10116, 100360427]], "id": 1471}, "interpro": [{"desc": "E2F/DP family, winged-helix DNA-binding domain", "id": "IPR003316", "short_desc": "E2F_WHTH_DNA-bd_dom"}, {"desc": "E2F Family", "id": "IPR015633", "short_desc": "E2F"}, {"desc": "E2F transcription factor, CC-MB domain", "id": "IPR032198", "short_desc": "E2F_CC-MB"}, {"desc": "Winged helix-like DNA-binding domain superfamily", "id": "IPR036388", "short_desc": "WH-like_DNA-bd_sf"}, {"desc": "Winged helix DNA-binding domain superfamily", "id": "IPR036390", "short_desc": "WH_DNA-bd_sf"}, {"desc": "E2F-DP heterodimerization region", "id": "IPR037241", "short_desc": "E2F-DP_heterodim"}], "ipi": "IPI00292880", "map_location": "16q22.1", "name": "E2F transcription factor 4", "other_names": ["E2F transcription factor 4, p107/p130-binding", "p107/p130-binding protein", "transcription factor E2F4"], "pantherdb": {"HGNC": "3118", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "103012", "ortholog_type": "LDO", "panther_family": "PTHR12081", "taxid": 10090, "uniprot_kb": "Q8R0K9"}, {"RGD": "2322129", "ortholog_type": "LDO", "panther_family": "PTHR12081", "taxid": 10116, "uniprot_kb": "D4A9V4"}, {"Ensembl": "ENSGALG00000001722", "ortholog_type": "LDO", "panther_family": "PTHR12081", "taxid": 9031, "uniprot_kb": "Q5ZJU1"}, {"ZFIN": "ZDB-GENE-040426-2773", "ortholog_type": "LDO", "panther_family": "PTHR12081", "taxid": 7955, "uniprot_kb": "A0A0R4ICD5"}, {"WormBase": "WBGene00001162", "ortholog_type": "O", "panther_family": "PTHR12081", "taxid": 6239, "uniprot_kb": "A5HWA8"}, {"WormBase": "WBGene00001161", "ortholog_type": "O", "panther_family": "PTHR12081", "taxid": 6239, "uniprot_kb": "G5EF11"}, {"FlyBase": "FBgn0024371", "ortholog_type": "O", "panther_family": "PTHR12081", "taxid": 7227, "uniprot_kb": "O77051"}, {"dictyBase": "DDB_G0284129", "ortholog_type": "O", "panther_family": "PTHR12081", "taxid": 352472, "uniprot_kb": "Q54Q23"}, {"TAIR": "2202390", "ortholog_type": "O", "panther_family": "PTHR12081", "taxid": 3702, "uniprot_kb": "Q9FV70"}, {"EnsemblGenome": "AT2G36010", "ortholog_type": "O", "panther_family": "PTHR12081", "taxid": 3702, "uniprot_kb": "Q9FNY0"}, {"TAIR": "3685148", "ortholog_type": "O", "panther_family": "PTHR12081", "taxid": 3702, "uniprot_kb": "Q9FV71"}], "uniprot_kb": "Q16254"}, "pathway": {"biocarta": {"id": "etspathway", "name": "mets affect on macrophage differentiation"}, "kegg": [{"id": "hsa04110", "name": "Cell cycle - Homo sapiens (human)"}, {"id": "hsa04218", "name": "Cellular senescence - Homo sapiens (human)"}, {"id": "hsa04350", "name": "TGF-beta signaling pathway - Homo sapiens (human)"}], "netpath": {"id": "Pathway_TGF_beta_Receptor", "name": "TGF_beta_Receptor"}, "pid": [{"id": "e2f_pathway", "name": "E2F transcription factor network"}, {"id": "rb_1pathway", "name": "Regulation of retinoblastoma protein"}], "reactome": [{"id": "R-HSA-1362277", "name": "Transcription of E2F targets under negative control by DREAM complex"}, {"id": "R-HSA-1362277", "name": "Transcription of E2F targets under negative control by DREAM complex"}, {"id": "R-HSA-1362300", "name": "Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1"}, {"id": "R-HSA-1538133", "name": "G0 and Early G1"}, {"id": "R-HSA-1538133", "name": "G0 and Early G1"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-1640170", "name": "Cell Cycle"}, {"id": "R-HSA-1640170", "name": "Cell Cycle"}, {"id": "R-HSA-170834", "name": "Signaling by TGF-beta Receptor Complex"}, {"id": "R-HSA-212436", "name": "Generic Transcription Pathway"}, {"id": "R-HSA-2173793", "name": "Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer"}, {"id": "R-HSA-2173796", "name": "SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription"}, {"id": "R-HSA-3700989", "name": "Transcriptional Regulation by TP53"}, {"id": "R-HSA-453279", "name": "Mitotic G1 phase and G1/S transition"}, {"id": "R-HSA-453279", "name": "Mitotic G1 phase and G1/S transition"}, {"id": "R-HSA-6791312", "name": "TP53 Regulates Transcription of Cell Cycle Genes"}, {"id": "R-HSA-6804114", "name": "TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest"}, {"id": "R-HSA-69202", "name": "Cyclin E associated events during G1/S transition "}, {"id": "R-HSA-69205", "name": "G1/S-Specific Transcription"}, {"id": "R-HSA-69205", "name": "G1/S-Specific Transcription"}, {"id": "R-HSA-69206", "name": "G1/S Transition"}, {"id": "R-HSA-69206", "name": "G1/S Transition"}, {"id": "R-HSA-69231", "name": "Cyclin D associated events in G1"}, {"id": "R-HSA-69236", "name": "G1 Phase"}, {"id": "R-HSA-69242", "name": "S Phase"}, {"id": "R-HSA-69278", "name": "Cell Cycle, Mitotic"}, {"id": "R-HSA-69278", "name": "Cell Cycle, Mitotic"}, {"id": "R-HSA-69656", "name": "Cyclin A:Cdk2-associated events at S phase entry"}, {"id": "R-HSA-73857", "name": "RNA Polymerase II Transcription"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}, {"id": "R-HSA-9006936", "name": "Signaling by TGFB family members"}], "wikipathways": [{"id": "WP179", "name": "Cell cycle"}, {"id": "WP236", "name": "Adipogenesis"}, {"id": "WP366", "name": "TGF-beta Signaling Pathway"}]}, "pdb": ["1CF7", "5TUU"], "pfam": ["PF02319", "PF16421"], "pharmgkb": "PA27576", "pharos": {"target_id": 12723, "tdl": "Tbio"}, "pir": "A55237", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF231305", "relationship": "is"}, {"id": "GNF248715", "relationship": "is"}, {"id": "GNF248716", "relationship": "is"}, {"id": "GNF248717", "relationship": "is"}, {"id": "GNF248718", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF043934", "relationship": "is"}, "GNF_mm+hs-MGC": [{"id": "GNF003928", "relationship": "is"}, {"id": "GNF017247", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF099469", "relationship": "is"}, {"id": "GNF139124", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000016.10", "NC_060940.1"], "protein": "NP_001941.2", "rna": "NM_001950.4", "translation": {"protein": "NP_001941.2", "rna": "NM_001950.4"}}, "reporter": {"HG-U133_Plus_2": ["202248_at", "38707_r_at"], "HG-U95Av2": ["1703_g_at", "1724_at", "38706_at", "38707_r_at"], "HTA-2_0": "TC16000533.hg.1", "HuEx-1_0": "3665288", "HuGene-1_1": "7996455", "HuGene-2_1": "16820041"}, "summary": "The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses. The E2F proteins contain several evolutionally conserved domains found in most members of the family. These domains include a DNA binding domain, a dimerization domain which determines interaction with the differentiation regulated transcription factor proteins (DP), a transactivation domain enriched in acidic amino acids, and a tumor suppressor protein association domain which is embedded within the transactivation domain. This protein binds to all three of the  tumor suppressor proteins pRB, p107 and p130, but with higher affinity to the last two. It plays an important role in the suppression of proliferation-associated genes, and its gene mutation and increased expression may be associated with human cancer. [provided by RefSeq, Jul 2008].", "symbol": "E2F4", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1414227"}, "unigene": "Hs.108371", "uniprot": {"Swiss-Prot": "Q16254", "TrEMBL": ["H3BTM3", "H3BVE4", "H3BMP3", "I3L1B6"]}, "wikipedia": {"url_stub": "E2F4"}}